Drug Shortage Report for FENTANYL CITRATE INJECTION USP

Last updated on 2018-09-10 History
Report ID 59185
Drug Identification Number 02240434
Brand name FENTANYL CITRATE INJECTION USP
Common or Proper name FENTANYL
Company Name SANDOZ CANADA INCORPORATED
Market Status MARKETED
Active Ingredient(s) FENTANYL
Strength(s) 50MCG
Dosage form(s) LIQUID
Route of administration INTRAMUSCULAR INTRAVENOUS EPIDURAL
Packaging size 10 X 2ML AMPOULES
ATC code N01AH
ATC description ANESTHETICS, GENERAL
Reason for shortage Demand increase for the drug.
Anticipated start date
Actual start date 2018-08-17
Estimated end date 2018-09-03
Actual end date 2018-09-03
Shortage status Resolved
Updated date 2018-09-10
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 110 RUE DE LAUZON
BOUCHERVILLE, QUEBEC
CANADA J4B 1E6
Company contact information 1 800-361-3062

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v4 2018-09-10 French Compare
v3 2018-09-10 English Compare
v2 2018-08-27 French Compare
v1 2018-08-27 English Compare

Showing 1 to 4 of 4